Advertisement
UK markets close in 2 hours 15 minutes
  • FTSE 100

    7,861.83
    +13.84 (+0.18%)
     
  • FTSE 250

    19,368.50
    +28.36 (+0.15%)
     
  • AIM

    743.71
    +0.59 (+0.08%)
     
  • GBP/EUR

    1.1685
    +0.0018 (+0.16%)
     
  • GBP/USD

    1.2460
    +0.0004 (+0.03%)
     
  • Bitcoin GBP

    49,940.61
    -10.27 (-0.02%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     
  • DOW

    37,753.31
    -45.66 (-0.12%)
     
  • CRUDE OIL

    82.99
    +0.30 (+0.36%)
     
  • GOLD FUTURES

    2,402.00
    +13.60 (+0.57%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,759.63
    -10.39 (-0.06%)
     
  • CAC 40

    7,998.26
    +16.75 (+0.21%)
     

Global Auto-Immune Diseases Diagnostic Testing Device Pipeline Report 2020

Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

"Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020". Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient's test sample.

Scope

  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

  • The report reviews the major players involved in the development of Auto-Immune Diseases Diagnostic Tests and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product's current stage of development, territory and estimated launch date

ADVERTISEMENT

Companies Mentioned

  • Aarhus University

  • Adaptive Biotechnologies Corp

  • Albert Ludwigs University of Freiburg

  • Alere Inc

  • Amarantus Diagnostics Inc

  • apDia nv

  • Autoimmune Technologies LLC

  • Beckman Coulter Inc

  • Bellvitge Biomedical Research Institute

  • BG Medicine Inc

  • Biogen Inc

  • BIOHOPE Scientific SL

  • Biomedal SL

  • Bionure Farma SL

  • CDI Laboratories Inc

  • Celdara Medical LLC

  • Charite University Hospital of Berlin

  • Chronix Biomedical Inc

  • Cincinnati Children's Hospital Medical Center

  • Columbia University

  • Crescendo Bioscience Inc

  • Digna Biotech SL

  • DNAlytics SA

  • Enterome Bioscience SA

  • Exodus Biosciences LLC

  • Ezose Sciences Inc.

  • Flamentera AG

  • Genalyte Inc

  • GeNeuro SA

  • Grifols SA

  • Hannover Medical School

  • HealthTell Inc

  • Helmholtz Centre for Infection Research

  • HOB Biotech Group Suzhou Co Ltd

  • Hospital for Special Surgery

  • Hycor Biomedical Inc

  • Ignyta Inc

  • Immunarray Pvt Ltd

  • Immunodiagnostic Systems Holdings plc

  • Immunovia AB

  • ImmusanT Inc

  • Innobiochips

  • Inova Diagnostics Inc

  • IPDx Immunoprofiling Diagnostics GmbH

  • Iquity Labs Inc

  • Iron Horse Diagnostics, Inc.

  • Johns Hopkins University

  • Lankenau Institute for Medical Research

  • LineaGen Inc

  • Lophius Biosciences GmbH

  • Louisville Bioscience Inc (Inactive)

  • Max Delbruck Center for Molecular Medicine

  • Medica Corp

  • Medical & Biological Laboratories Co Ltd

  • Metabiomics Corporation

  • Metabolomic Technologies Inc

  • Metanomics Health GmbH

  • MSDx Inc

  • Myriad Genetics Inc

  • Nanosphere Inc

  • Neuro Vigor LLC

  • Northwestern University

  • NoToPharm srl

  • Numares AG

  • OmniBiome Therapeutics Inc

  • One Way Liver SL

  • OPKO Health Inc

  • Op-T-Mune Inc

  • Oxford Gene Technology Ltd

  • Oxford Immunotec Ltd

  • Pediatric Bioscience LLC

  • Penn State College of Medicine

  • ProciseDx LLC

  • Progentec Diagnostics Inc

  • Protagen AG

  • ProteinLogic Ltd

  • Quanterix Corp

  • Rambam Health Care Campus

  • Rappaport Family Institute for Research in the Medical Science

  • Regulus Therapeutics Inc

  • Roche Diagnostics International Ltd

  • Seattle Children's Hospital

  • Sengenics Corp Pte Ltd

  • Sequenom Inc

  • Shuwen Biotech Co Ltd

  • SomaLogic Inc

  • Southern Illinois University Carbondale

  • SQI Diagnostics Inc

  • Statens Serum Institut

  • Svar Life Science AB

  • TBG Diagnostics Ltd

  • The University of Manchester

  • The Walter and Eliza Hall Institute of Medical Research

  • Toscana Biomarkers Srl

  • University Health Network

  • University of Alberta

  • University of California San Francisco

  • University of Chicago

  • University of Colorado

  • University of Illinois at Chicago

  • University of Maryland Baltimore

  • University of Missouri

  • University of Oslo

  • University of Oxford

  • University of Pecs

  • University of Southern California

  • University Rovira i Virgili

  • US Biomarkers Inc

  • Washington University in St Louis

  • XEPTAGEN SpA

  • Yale University

For more information about this report visit https://www.researchandmarkets.com/r/ile173

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900